We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Expression Analysis Awarded EPA Contract for ToxCast™ Genomic Services
News

Expression Analysis Awarded EPA Contract for ToxCast™ Genomic Services

Expression Analysis Awarded EPA Contract for ToxCast™ Genomic Services
News

Expression Analysis Awarded EPA Contract for ToxCast™ Genomic Services

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Expression Analysis Awarded EPA Contract for ToxCast™ Genomic Services"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Expression Analysis, Inc. has announced that the United States Environmental Protection Agency (EPA) awarded it a major contract for genomic services in the Agency’s ToxCast™ Program.

Expression Analysis will provide gene expression and genotyping services using microarrays from Affymetrix and Illumina, as well as TaqMan PCR assays from Applied Biosystems.

Steve McPhail, President & CEO of Expression Analysis, said, “We are delighted to continue our relationship with the EPA. In 2003, we were awarded a multi-million dollar contract from the Agency, which was extended and expanded in 2005. The ToxCast™ award demonstrates that the EPA perceives us as a high-quality, high-value provider of genomic services.”

Expression Analysis recently moved to a larger facility in Durham, NC and expanded its genomic service offerings.

“Over the past year, our Affymetrix infrastructure has dramatically increased and we have added many new services based on the Illumina and ABI TaqMan platforms,” McPhail continued, “These investments allowed us to present the EPA with an attractive suite and continuum of genomic services.”

The ToxCast™ Program will be managed by the National Center for Computational Toxicology of EPA. It is designed to provide an efficient, science-based prioritization of environmental chemicals for more detailed toxicological evaluations. ToxCast™ will encompass two phases over multiple years.

The first, proof-of-concept phase will involve over 300 chemicals, selected to include a diversity of chemical structures and toxicological profiles. The second phase will apply the approach to environmental chemicals of concern to the Agency.

Advertisement